FOXD3‐AS1 is strongly expressed in a range of disorders, including breast cancer, nasopharyngeal carcinoma, osteosarcoma, melanoma, and thyroid cancer.37 The gene discussed is FOXD3; the disease is nasopharyngeal carcinoma.